Question

Admission for anemia with adverse effect of chemotherapy or immunotherapy and only treatment is for anemia.

1) True
2) False

Answer 1

Anemia can indeed occur as a result of the adverse effects of chemotherapy or immunotherapy because chemotherapy can lead to the destruction of erythrocytes and other blood cells. In acute myelogenous leukemia, patients would likely experience impaired production of erythrocytes. For chemotherapy treatment, an ANC of 1900 cells per microliter is within the range considered acceptable to proceed.

Step-by-step explanation:

Impact of Chemotherapy on Blood Cell Production

When considering whether anemia during an adverse effect of chemotherapy or immunotherapy is true, it is essential to understand that one of the primary adverse effects of chemotherapy is the destruction of blood cells, including erythrocytes (red blood cells), leukocytes (white blood cells), and thrombocytes (platelets). As a result, a patient receiving chemotherapy can indeed develop anemia, a condition characterized by a deficiency in the number or function of erythrocytes.
This anemia can arise due to the myelosuppressive nature of chemotherapy, which affects the bone marrow's ability to produce new cells, including erythrocytes, leading to a reduction in red blood cell counts and subsequent anemia.

With regard to the question on acute myelogenous leukemia, a patient would likely experience an impaired production of erythrocytes since this type of cancer directly affects the myeloid cells in the bone marrow, which are responsible for producing erythrocytes, among other cell types. This impairment leads to a decrease in the production of these cells, thus contributing to anemia.

Looking at the scenario of a patient undergoing chemotherapy treatment, a healthcare team will evaluate the absolute neutrophil count (ANC) to make decisions related to continuing with chemotherapy. An ANC of 1900 cells per microliter is typically considered within the acceptable range to proceed with chemotherapy. However, this decision must also take into consideration the patient's overall health status, as well as other factors that could influence treatment.